Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup-A Pilot Descriptive Study

NCT01465360 is registered in ClinicalTrials.gov with Exonhit as lead sponsor.

NCT NCT01465360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01465360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup-A Pilot Descriptive Study
Lead sponsor
Exonhit
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
Not reported
Enrollment
160 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, fronto-temporal dementia, mild cognitive impairment, mixed dementia, parkinson' disease dementia, primary progressive aphasia, vascular dementia